• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of the method for chromosomal site-specific integration of transgenes using AAV and its application to hematopoietic cells

Research Project

Project/Area Number 10470213
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionJichi Medical School

Principal Investigator

OZAWA Keiya  Jichi Medical School, Faculty of Medicine, Professor, 医学部, 教授 (30137707)

Co-Investigator(Kenkyū-buntansha) URABE Masashi  Jichi Med. Sch., Faculty of Medicine, Research Associate, 医学部, 助手 (40213516)
KUME Akihiro  Jichi Med. Sch., Faculty of Medicine, Assistant Professor, 医学部, 講師 (10264293)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥10,300,000 (Direct Cost: ¥10,300,000)
Fiscal Year 1999: ¥4,600,000 (Direct Cost: ¥4,600,000)
Fiscal Year 1998: ¥5,700,000 (Direct Cost: ¥5,700,000)
KeywordsGene theray / Gene transfer / Integration / AAV / AAVSI locus / Rep / ITR / TVI method
Research Abstract

Targeted integration of foreign DNA (TVI:targeted vector integration) is desirable for safe gene therapy. Adeno-associated virus (AAV) has the ability to integrate its genome into a defined locus, AAVS1 (19q13.3-qter). The inverted terminal repeat (ITR) at both ends of the AAV genome and Rep proteins are responsible for this site-specific integration. Therefore, two AAV components, Rep and ITR, are utilized to develop the TVI system. A mutant Rep protein that lacks cytotoxicity while retaining the ability to mediate AAVS1-specific integration is an attractive molecule for this system. We constructed plasmids containing the genes encoding mutant Rep proteins, in which all the charged amino acids in the N-terminal region were mutated to alanine. We found several mutants showed lower cytotoxicity, compared to the wild type Rep protein, without losing the ability of the site-specific integration. We are further screening a more suitable mutant Rep for the AAVS1-directed integration of genes. To analyze detailed mechanism of Rep-mediated integration, we amplified junctional regions between cellular and transgene sequences by using an Alu-PCR technique. The TVI system is valuable especially when dividing cells such as hematopoietic cells are transduced and long-term transgene expression is needed. We have showed that this TVI system could introduce a transgene into AAVS1 in K562 cells.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (60 results)

All Other

All Publications (60 results)

  • [Publications] Matsuda, K.M.: "A novel strategy for the tumor angigenesis-targeted gene therapy: Generation of angiostatin endogenous plasminogen by protease gene transfer"Cancer Gene Ther.. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Urabe, M.: "DNA/calcium phosphate precipitates mixed with medium are stable and maintain high transduction efficiency"Anal. Biochem.. 278. 91-92 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Maeda, Y.: "Endogenously generated nitric oxide by nitric-oxide synthase gene transfer inhibit cellular proliferation"J. Phamacol. Exp. Therapeut.. 292. 387-393 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ogasawara, Y.: "Potential application of dominant negative retinoic acid receptor genes for ex vivo expansion of hematopoietic stem cells."Gene Ther. Mol Biol.. 3. 293-300 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Oigasawara, Y.: "Highly-regulated expression of adeno-associated virus large Rep proteins in stable 293 cell lines using the Cre-loxP switching system."J. Gen. Virol.. 80. 2477-2480 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Xu, R.: "A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells"J. Gene Med.. 1. 236-244 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Matsuda, K. M.: "Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy"Gene Ther.. 6. 1039-1044 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kume A,: "Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors"Stem Cells. 17. 226-232 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kume, A.: "A G-CSF receptor gyrase B fusion gene: a new type of molecular switch for expansion of genetically modified hematopoietic cells."Biochem. Biophys. Res. Commun.. 260. 9-12 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ozawa, K.: "Strategies for gene therapy of Parkinson's disease using adeno-associated virus(AAV) vectors"Biogenetic Amines. 15. 21-37 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ogasawara, Y.: "Efficient production of adeno-associated virus vectors using split type helper plasmids"Jpn. J. Cnacer Res.. 90. 476-483 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Urabe, M.: "Chaged-to-alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 protein."J. Virol.. 73. 2683-2693 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kodaira, H.: "Fas and mutant estrogen receptor chimeric gene: a novel suicide vector for tarmoxifen-inducible apoptosis"Jpn. J. Cancer Res.. 89. 741-747 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kokubun M.: "Apoptosis-mediated regulation of recombinant human granulocyte colony-stimulating factor production by genetically engineered fibroblasts"Gene Ther.. 5. 923-929 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ozawa, K.: "A novel selective amplifier gene for hematopoietic stem cell gene therapy"Cancer Res. Ther. Contr.. 7. 27-31 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Fan, D.: "Prevention of dopaminergic neuron death by adeno-associated virus vector mediated GDNF gene transfer in rat mesencephalic cells in vitro"Neurosci. Lett.. 248. 61-64 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Maeda, Y.: "Efficient gene transfer into cardiac myocytes using adeno-associated virus(AAV) vectors"J. Mol. Cell. Cardiol. 30. 1341-1348 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ogasawara, Y.: "The use of heterologous promoters for adeno-associated virus(AAV) protein expression in AAV vector production"Microbiol. Immunol.. 42. 177-185 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Matsuda,K.M.,Madoiwa,S., Hasumi,Y., Kanazawa,T., Saga,Y., Kume,A., Mano,H., Ozawa.K.. And Matsuda,M.: "A novel strategy for the tumor angiogenesis-targeted gene therapy: Generation of angiostatin endogenous plasminogen by protease gene transfer."Cancer Gene Ther.. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Urabe,M., Kume,A., Tobita,K., and Ozawa,K.: "DNA/calcium phosphate precipitates mixed with medium are stable and maintain high transduction efficiency."Anal. Biochem.. 278. 91-92 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Maeda,Y., Ikeda,U., Oya,K., Shimpo,M., Ueno,S., Okada,K., Saito,T., Mano,H., Ozawa,K.: and Shimada, K.: "Endogenously generated nitric oxide by nitric-oxide synthase gene transfer inhibits cellular proliferation."J. Phamacol. Exp. Theraeut.. 292. 387-393 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ogasawara, Y., Hanazono, Y., Kodaira, H., Urabe, M., Mano, H., Kakizuka, A., Kume, A., and Ozawa,K.: "Potential application of dominant negative retinoic acid receptor genes for ex vivo expansion of hematopoietic stem cells."Gene Ther. Mol. Biol.. 3. 293-300 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ogasawara, Y., Mizukami, H., Urabe, M., Kume, A., Kanegae, Y., Saito, I., Monahan, J., and Ozawa.K.: "Highly-regulated expression of adeno-associated virus large Rep proteins in stable 293 cell lines using the Cre-loxP switching system."J. Gen. Virol. 80. 2477-2480 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Xu,R., Kume,A., Matsuda,K.M., Ueda,Y., Kodaira,H., Ogasawara,Y., Urabe,M., Kato,I., Hasegawa,M., and Ozawa,K.: "A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells."J. Gene Med.1. 1. 236-244 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Matsuda,K.M., Kume,A., Ueda,Y., Urabe, M., Hasegawa,M., and Ozawa.K.: "Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy."Gene Ther.. 6. 1038-1044 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kume, A., Hashiyama, M., Suda, T., and Ozawa, K.: "Green fluorescent protein as a selectable marker of retrovirally transduced hematopoletic progenitors."Stem Cells. 17. 226-232 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kume,A., Ito,K., Ueda,Y., Hasegawa,M., Urabe,M., Mano,H., and Ozawa K.: "AG-CSF receptor-gyrase B fusion gene: a new type of molecular switch for expansion of geneticlly modified hematopoiec cells."Biochem. Biophys. Res. Commun.. 260. 9-12 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ozawa,K., Fan, D., Ogawa,M., Urabe,M., Kume,A., Monahan,J., and Nakano,I.: "Strategies for gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors."Biogenic Amines. 15. 21-37 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ogasawara,Y., Urabe,M., Kogure,K., Kume,A., Colosi,P., Kurtzman,G.J., and Ozawa,K.: "Efficient production of adeno-associated virus vectors using split-type helper plasmids."Jpn.J. Cancer Res.. 90. 476-483 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Urabe, M., Hasumi, Y., Kume, A., Surosky, R.T., Kurtzman, J., Tobita, K., and Ozawa.K.: "Charged-to-alanine scanning mutagenesis of N-terminal half of adeno-associated virus type 2 Rep 78 protein."J.Virol. 73. 2682-2693 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kodaira, H., Kume, A., Ogasawara, Y., Urabe, M., Kitano, K., Kakizuka, A., and Ozawa.K.: "Fas and mutant estrogen receptor chimeric gene: a novel suicide vector for tamoxifen-inducible apoptosis."Jpn. J. Cancer Res.. 89. 741-747 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kokubun,M., Kume,A., Urabe,M., Mano,H., Okubo, M., Kasukawa,R., Kakizuka,A., and Ozawa,K.: "Apoptosis-mediated regulation of recombinant human granulocyte colony-stimulating factor production by genetically engineered fibroblasts."Gene Ther.. 5. 923-929 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ozawa,K., Ueda, Y., Ito,K., Urabe,M., Kume,A., Sakata,T., and Hasagawa,M.: "A novel selective amplifier gene for hematopoietic stem cell gene therapy."Cancer Res. Ther. Contr.. 7. 27-31 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Fan,D., Ogawa,M., Ikeguchi,K., Fujimoto,K., Urabe,M., Kume,A., Nishizawa,M., Matsushita,N., Kiuchi,K., Ichinose,H., Nagatsu,T., Kurtzman,G.J., Nakano,I., and Ozawa.K.: "Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro."Neurosci. Lett.. 248. 61-64 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Maeda,Y., Ikeda,U., Shimpo,M.,Ueno,S., Ogasawara,Y.,Urabe,M., Kume,A., Takizawa,T., Saito,T., Colosi,P., Kurtzman,G., Shimada,K., and Ozawa.K.: "Efficient gene transfer into cardiac myocytes using adeno-associated virus (AAV) vectors."J. Mol. Cell. Cardiol.. 30. 1341-1348 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ogasawara,Y., Urabe,M., and Ozawa,K.: "The use of heteologous promoters for adeno-associate virus(AAV) protein expression in AVV vector production."Microbiol. Immunol.. 42. 177-185 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Matsuda,K.M.: "A novel strategy for the tumor angiogenesis-targeted gene therapy : Generation of angiostatin endogenous plasminogen by protease gene transfer"Cancer Gene Ther.. (in press).

    • Related Report
      1999 Annual Research Report
  • [Publications] Urabe,M.: "DNA/calcium phosphate precipitates mixed with medium are stable and maintain high transduction efficiency"Anal.Biochem.. 278. 91-92 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Maeda,Y.: "Endogenously generated nitric oxide by nitric-oxide synthase gene transfer inhibits cellular proliferation"J.Phamacol.Exp.Therapeut.. 292. 387-393 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ogasawara,Y.: "Potential application of dominant negative retinoic acid receptor genes for ex vivo expansion of hematopoietic stem cells"Gene Ther.Mol.Biol.. 3. 293-300 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ogasawara,Y.: "Highly-regulated expression of adeno-associated virus large Rep proteins in stable 293 cell lines using the Cre-loxP switching system"J.Gen.Virol.. 80. 2477-2480 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Xu,R.: "A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells"J.Gene Med.. 1. 236-244 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Matsuda,K.M.: "Development of a modified selective a mplifier gene for hematopoietic stem cell gene therapy"Gene Ther.. 6. 1038-1044 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kume,A.: "Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors"Stem Cells. 17. 226-232 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kume,A.: "A G-CSF receptor-gyrase B fusion gene : a new type of molecular switch for expansion of genetically modified hematopoietic cells"Biochem.Biophys.Res.Commun.. 260. 9-12 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ozawa,K.: "Strategies for gene therapy of Parkinson's disease using adeno-associated virus(AAV) vectors"Biogenic Amines. 15. 21-37 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ogasawara,Y.: "Efficient production of adeno-associated virus vectors using split-type helper plasmids"Jpn.J.Cancer Res.. 90. 476-483 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Urabe,M.: "Charged-to-alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep 78 protein"J.Virol.. 73. 2682-2693 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ogasawara,Y.: "Efficient production of adeno-associated virus vectors using split-type helper plasmids" Jpn.J.Cancer Res.(in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] Matsda,K.M.: "Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy" Gene Ther.(in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] Urabe ,M.: "Charged-to-alanine scanning mutagenesis of N-terminal half of adeno-associated virus type 2 Rep78 protein" J.Virol.(in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] Ogasawara,Y.: "Potential application of dominant negative retinoic acid receptor genes for ex vivo expansion of hematopoietic stem cells" Gene Ther.Mol.Biol.(in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] Ozawa,K.: "Strategies for gene therapy of Parkinson's disease using adeno-associated virus(AAV) vectors" Biogenic Amines. (in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] Fan,D.: "Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors" Hum.Gene Ther.9. 2527-2535 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Kodaira,H.: "Fas and mutant estrogen receptor chimeric gene: a novel suicide vector for tamoxifen-inducible apoptosis" Jpn.J.Cancer Res.89. 741-747 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Kokubun,M.: "Apoptosis-mediated regulation of recombinant human granulocyte colony-stimulating factor production by genetically engineered fibroblasts" Gene Ther.5. 923-929 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ozawa,K.: "A novel selective amplifier gene for hematopoietic stem cell gene therapy" Cancer Res.Ther.Contr.7. 27-31 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Fan,D.: "Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro" Neurosci.Lett.248. 61-64 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Maeda,Y.: "Efficient gene transfer into cardiac myocytes using adeno-associated virus(AAV)vectors" J.Mol.Cell.Cardiol.30. 1341-1348 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ogasawara,Y.: "The use of heterologous promoters for adeno-associated virus(AAV)protein expression in AAV vector production" Microbiol.Immunol.42. 177-185 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi